Pertuzumab, trastuzumab, and docetaxel for Chinese patients with previously untreated HER2-positive locally recurrent or metastatic breast cancer (PUFFIN): final analysis of a phase III, randomized, double-blind, placebo-controlled study
Titel:
Pertuzumab, trastuzumab, and docetaxel for Chinese patients with previously untreated HER2-positive locally recurrent or metastatic breast cancer (PUFFIN): final analysis of a phase III, randomized, double-blind, placebo-controlled study
Auteur:
Xu, Binghe Li, Wei Zhang, Qingyuan Li, Qiao Wang, Xiaojia Li, Huiping Sun, Tao Yin, Yongmei Zheng, Hong Feng, Jifeng Zhu, Huaqi Siddiqui, Asna Macharia, Harrison Knott, Adam